Biblio Discovery — Demo Discovery Service

15 hasil untuk "Robert B. Den"

Menampilkan 1–15 · 0,89 detik · RSS

  1. Artikel Jurnal

    Heat shock protein 90 inhibition: rationale and clinical potential

    Robert B. Den; Bo Lu

    Therapeutic Advances in Medical Oncology, Vol. 4 · 2012 · Inggris · DOAJ Scopus

    Heat shock protein 90 (HSP90) is a molecular chaperone protein essential for cellular survival. Functionally, HSPs promote proper protein folding, prevent misfolding, and restore three-dimensional protein structure which is critical following toxic cellular stresses. Recently, targeting HSP90…

  2. Artikel Jurnal

    Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions

    Benjamin A. Greenberger; Victor E. Chen; Robert B. Den

    Frontiers in Oncology, Vol. 9 · 2019 · Inggris · DOAJ Scopus

    Despite the many prospective randomized trials that have been available in the past decade regarding the optimization of radiation, hormonal, and surgical therapies for high-risk prostate cancer (PCa), many questions remain. There is currently a lack of level I evidence regarding the relative…

  3. Artikel Jurnal

    SpaceOAR to improve dosimetric outcomes for monotherapy high-dose-rate prostate implantation in a patient with ulcerative colitis

    Michael Trager; Benjamin Greenberger; Amy S Harrison dkk.

    Journal of Contemporary Brachytherapy, Vol. 10 No. 6 · 2018 · Inggris · DOAJ Scopus

    High-dose-rate (HDR) brachytherapy is an attractive option for patients receiving definitive radiation therapy for prostate cancer with decreased overall dose to the pelvis. However, ulcerative colitis increases rectal toxicity risk and may be a contraindication. A synthetic hydrogel, SpaceOAR…

  4. Artikel Jurnal

    Radioisotopes in management of metastatic prostate cancer

    Amar Raval; Tu D Dan; Noelle L Williams dkk.

    Indian Journal of Urology, Vol. 32 No. 4 · 2016 · Inggris · DOAJ Scopus

    Introduction: Metastatic prostate cancer continues to be a leading cause of morbidity and mortality in men with prostate cancer. Over the last decade, the treatment landscape for patients with castrate-resistant disease has drastically changed, with several novel agents demonstrating an improvement…

  5. Artikel Jurnal

    Biodistribution and Pharmacokinetics Study of siRNA-loaded Anti-NTSR1-mAb-functionalized Novel Hybrid Nanoparticles in a Metastatic Orthotopic Murine Lung Cancer Model

    Maryna Perepelyuk; Chellappagounder Thangavel; Yi Liu dkk.

    Molecular Therapy: Nucleic Acids, Vol. 5 No. C · 2016 · Inggris · DOAJ Scopus

    Small interfering RNA (siRNA) is effective in silencing critical molecular pathways in cancer. The use of this tool as a treatment modality is limited by lack of an intelligent carrier system to enhance the preferential delivery of this molecule to specific targets in vivo. In the present study…

  6. Artikel Jurnal

    Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts

    Yossi Nishri; Maayan Vatarescu; Ishai Luz dkk.

    Frontiers in Oncology, Vol. 12 · 2022 · Inggris · DOAJ Scopus

    Glioblastoma multiforme (GBM) is at present an incurable disease with a 5-year survival rate of 5.5%, despite improvements in treatment modalities such as surgery, radiation therapy, chemotherapy [e.g., temozolomide (TMZ)], and targeted therapy [e.g., the antiangiogenic agent bevacizumab (BEV)]…

  7. Artikel Jurnal

    siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer

    Maryna Perepelyuk; Olubunmi Shoyele; Ruth Birbe dkk.

    Molecular Therapy: Nucleic Acids, Vol. 6 · 2017 · Inggris · DOAJ Scopus

    There is an unmet need in the development of an effective therapy for mutant K-ras-expressing non-small-cell lung cancer (NSCLC). Although various small molecules have been evaluated, an effective therapy remains a dream. siRNAs have the potential to downregulate mutant K-ras both at the protein…

  8. Artikel Jurnal Teks lengkap

    Evaluating the clinical impact of a genomic classifier in prostate cancer using individualized decision analysis.

    Jennifer Mason Lobo; Adam P Dicker; Christine Buerki dkk.

    PLoS ONE, Vol. 10 No. 3 · 2015 · Inggris · DOAJ Scopus

    BackgroundCurrently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved curative results, but there is uncertainty in which patients should receive adjuvant therapy. There…

    Juga tersedia di: PLOS

  9. Artikel Jurnal

    Impact of Decipher on use of post‐operative radiotherapy: Individual patient analysis of two prospective registries

    Mohammed Shahait; Vinnie Y. T. Liu; Neha Vapiwala dkk.

    BJUI Compass, Vol. 2 No. 4 · 2021 · Inggris · DOAJ Scopus

    Abstract Objective To assess the association between Genomic Classifier (GC)‐risk group and post‐radical prostatectomy treatment in clinical practice. Methods Two prospective observational cohorts of men with prostate cancer (PCa) who underwent RP in two referral centers and had GC testing…

  10. Artikel Jurnal

    Variation in Molecularly Defined Prostate Tumor Subtypes by Self-identified Race

    Kevin H. Kensler; Shivanshu Awasthi; Mohamed Alshalalfa dkk.

    European Urology Open Science, Vol. 40 · 2022 · Inggris · DOAJ Scopus

    Background: Socioeconomic and health care utilization factors are major drivers of prostate cancer (PC) mortality disparities in the USA; however, tumor molecular heterogeneity may also contribute to the higher mortality among Black men. Objective: To compare differences in PC subtype frequency and…

  11. Artikel Jurnal

    Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report

    Hyun Kim; Mohammed Alshalalfa; Jean Hoffman-Censits dkk.

    Urology Case Reports, Vol. 9 No. C · 2016 · Inggris · DOAJ Scopus

    Management of men with prostate cancer is fraught with uncertainty as physicians and patients balance efficacy with potential toxicity and diminished quality of life. Utilization of genomics as a prognostic biomarker has improved the informed decision-making process by enabling more rationale…

  12. Artikel Jurnal

    Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer

    Lingjian Yang; Darren Roberts; Mandeep Takhar dkk.

    EBioMedicine, Vol. 31 · 2018 · Inggris · DOAJ Scopus

    Background: Hypoxia is associated with a poor prognosis in prostate cancer. This work aimed to derive and validate a hypoxia-related mRNA signature for localized prostate cancer. Method: Hypoxia genes were identified in vitro via RNA-sequencing and combined with in vivo gene co-expression analysis…

  13. Artikel Jurnal

    Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences

    Walter Rayford; Alp Tuna Beksac; Jordan Alger dkk.

    Communications Biology, Vol. 4 No. 1 · 2021 · Inggris · DOAJ Scopus

    Walter Rayford, Alp Tuna Beksac et al. investigated gene expression alterations in African-American and European-American men who underwent radical prostatectomy for prostate cancer. The observed differences include higher expression of inflammation genes and lower expression of mismatch repair…

  14. Artikel Jurnal

    High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

    David P. Labbé; Giorgia Zadra; Meng Yang dkk.

    Nature Communications, Vol. 10 No. 1 · 2019 · Inggris · DOAJ Scopus

    Prostate cancer progression may be enhanced by a high-fat diet. Here the authors show that a diet high in saturated fats enhance the MYC-driven transcriptional program, a feature that independently predicts prostate cancer progression and death.